These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 624774)
21. Depression of myocardial contractile function by propoxyphene and norpropoxyphene. Amsterdam EA; Rendig SV; Henderson GL; Mason DT J Cardiovasc Pharmacol; 1981; 3(1):129-38. PubMed ID: 6160342 [No Abstract] [Full Text] [Related]
22. In vitro metabolism of propoxyphene in rat liver: reaction of a carbinol metabolite with acetaldehyde. Hermansson I; Hermansson J; Stjernström NE Acta Pharmacol Toxicol (Copenh); 1983 Oct; 53(4):257-64. PubMed ID: 6650176 [TBL] [Abstract][Full Text] [Related]
23. Maternal and fetal blood/brain distribution of d-propoxyphene and norpropoxyphene in rat and dog. Due SL; Sullivan HR; Cochrane RL; Page JG; McMahon RE Toxicol Appl Pharmacol; 1981 Apr; 58(2):194-202. PubMed ID: 7245195 [No Abstract] [Full Text] [Related]
24. Ethanol interaction with propoxyphene and norpropoxyphene metabolism in isolated rat hepatocytes. Olsen H; Bodd E; Meyer T; Mørland J Pharmacol Biochem Behav; 1983; 18 Suppl 1():301-4. PubMed ID: 6634844 [TBL] [Abstract][Full Text] [Related]
25. Synthesis of new d-propoxyphene derivatives and the development of a microparticle-based immunoassay for the detection of propoxyphene and norpropoxyphene. Wu RS; McNally AJ; Pilcher IA; Salamone SJ; Rashid S Bioconjug Chem; 1997; 8(3):385-90. PubMed ID: 9177845 [TBL] [Abstract][Full Text] [Related]
26. Effect of l-propoxyphene on plasma levels and analgesic activity of d-propoxyphene in the rat. Murphy PJ; Nickander RC; Bellamy GM; Kurtz WL J Pharmacol Exp Ther; 1976 Nov; 199(2):415-22. PubMed ID: 978493 [TBL] [Abstract][Full Text] [Related]
27. Enhancement of propoxyphene bioavailability by ethanol. Relation to psychomotor and cognitive function in healthy volunteers. Girre C; Hirschhorn M; Bertaux L; Palombo S; Dellatolas F; Ngo R; Moreno M; Fournier PE Eur J Clin Pharmacol; 1991; 41(2):147-52. PubMed ID: 1743247 [TBL] [Abstract][Full Text] [Related]
28. Simultaneous quantitation of meperidine, normeperidine, tramadol, propoxyphene and norpropoxyphene in human plasma using solid-phase extraction and gas chromatography/mass spectrometry: Method validation and application to cardiovascular safety of therapeutic doses. Fernández N; Olivera NM; Keller GA; Diez RA; Di Girolamo G; Quiroga PN Rapid Commun Mass Spectrom; 2017 Sep; 31(18):1519-1533. PubMed ID: 28686794 [TBL] [Abstract][Full Text] [Related]
29. Plasma protein binding of azapropazone in patients with kidney and liver disease. Jähnchen E; Blanck KJ; Breuing KH; Gilfrich HJ; Meinertz T; Trenk D Br J Clin Pharmacol; 1981 Apr; 11(4):361-7. PubMed ID: 7259929 [TBL] [Abstract][Full Text] [Related]
30. Propoxyphene and norpropoxyphene quantitation in the same solid-phase extraction using Toxi-Lab Spec VC MP3 system. King JW; King LJ J Anal Toxicol; 1994; 18(4):217-9. PubMed ID: 7967543 [TBL] [Abstract][Full Text] [Related]
31. Quantitation of propoxyphene and its major metabolites in heroin addict plasma after large dose administration of propoxyphene napsylate. Nash JF; Bennett IF; Bopp RJ; Brunson MK; Sullivan HR J Pharm Sci; 1975 Mar; 64(3):429-33. PubMed ID: 1151627 [TBL] [Abstract][Full Text] [Related]
32. Propoxyphene and norpropoxyphene kinetics after single and repeated doses of propoxyphene. Inturrisi CE; Colburn WA; Verebey K; Dayton HE; Woody GE; O'Brien CP Clin Pharmacol Ther; 1982 Feb; 31(2):157-67. PubMed ID: 7056023 [TBL] [Abstract][Full Text] [Related]
33. Determination of dextropropoxyphene and norpropoxyphene in plasma by high-performance liquid chromatography. Pettersson KJ; Nilsson LB J Chromatogr; 1992 Oct; 581(1):161-4. PubMed ID: 1430002 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic interaction of propoxyphene with ethanol. Sellers EM; Hamilton CA; Kaplan HL; Degani NC; Foltz RL Br J Clin Pharmacol; 1985 Mar; 19(3):398-401. PubMed ID: 3986091 [TBL] [Abstract][Full Text] [Related]
35. Propoxyphene and norpropoxyphene: influence of type of controlled-release formulation on intra- and intersubject variations. Bechgaard H; Baggesen S J Pharm Sci; 1980 Nov; 69(11):1327-30. PubMed ID: 7452465 [TBL] [Abstract][Full Text] [Related]
36. Pharmacologic and toxic effects in animals of dextropropoxyphene and its major metabolite norpropoxyphene: a review. Nickander RC; Emmerson JL; Hynes MD; Steinberg MI; Sullivan HR Hum Toxicol; 1984 Aug; 3 Suppl():13S-36S. PubMed ID: 6090306 [No Abstract] [Full Text] [Related]
37. Cardio-respiratory toxicity of propoxyphene and norpropoxyphene in conscious rabbits. Lund-Jacobsen H Acta Pharmacol Toxicol (Copenh); 1978 Mar; 42(3):171-8. PubMed ID: 580345 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic studies of propoxyphene I:Effect of portacaval shunt on systemic availability in dogs. Giacomini KM; Nakeeb SM; Levy G J Pharm Sci; 1980 Jul; 69(7):786-9. PubMed ID: 7391940 [No Abstract] [Full Text] [Related]